Ireland
--:--IST
Latest
PulseAI of Belfast Says FDA Cleared Its Wearable ECG AI Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch PulseAI of Belfast Says FDA Cleared Its Wearable ECG AI Airmid Éireann 1.6 Adds India and China Trials, Swiss Prices Irish Cancer Trial Enrolment at 2.9%, Under Half 6% Target FDA Accelerated Approval for J&J's Head and Neck Cancer Drug Korea Misses 2026 Biosimilar Approvals, Bets on Keytruda ArrayPatch Closes €3.2m Seed for GLP-1 Microneedle Patch
Clinical Trials in Ireland / NCT02050750
Active, not recruiting Observational

TAILORx Tissue Bank

NCT02050750 · tracked via the Priya Life Science Ireland tracker
Sponsor
Cancer Trials Ireland
Phase
Observational
Started
2013-12
Last updated
2025-12-19

Condition(s) studied

Breast Cancer

Study summary

This is an exploratory, translational, non-interventional and multi-centre biobank. The aim of the development of such a biobank is to identify potential biomarkers that are indicative of disease relapse.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * Patients that were registered with the ICORG 06-31 TAILORx trial and participated in trial arms * Patients with adequate tumor tissue available

Primary outcome measure(s)

  • Disease relapse, endocrine and/or chemotherapy resistance prognosis — For duration of follow up, expected 10 years
    A biobank, TMAs and full face sections, will allow for the identification of candidate/novel biomarkers prognostic for disease relapse and predictive for endocrine and/or chemotherapy resistance

Trial sites (12)

FacilityCityRegionStatus
Bons Secours Hospital Cork Ireland
Cork University Hospital Cork Ireland
Letterkenny General Hospital Donegal Ireland
Adelaide and Meath National Children's Hospital Tallaght Dublin Ireland
St Vincent Universtiy Hospital Dublin Ireland
St James Hospital Dublin Ireland
Beaumont Hospital Dublin Ireland
Mater Misericordiae University Hospital Dublin Ireland
Galway University Hospital Galway Ireland
Midwestern Regional Hospital Limerick Ireland
Sligo General Hosptial Sligo Ireland
Waterford Regional Hospital Waterford Ireland

More Cancer Trials Ireland trials in Ireland

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas) Recruiting
'SOURCE - LUNG' Stereotactic Ablative Radiation Therapy Of UltRaCEntral LUNG Tumours (SOURCE Lung) Recruiting
Spine SABR - Dose-escalated Stereotactic Ablative Body Radiotherapy (SABR) for Solid Tumour Spine Metastases Recruiting
Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study) Active, not recruiting
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 Active, not recruiting

Other trials for the same condition

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) Active, not recruiting
Patient-Initiated Follow-Up for Women After Early Breast Cancer Treatment (LYSA2PIFU) Starting soon
The Effect of a Post-operative Exercise Programme Versus Standard Care on Physical Fitness of Patients With Breast Cancer Undergoing Deep Inferior Epigastric Perforator (DIEP) Flap Reconstruction Surgery Recruiting
PALbociclib CoLlaborative Adjuvant Study Active, not recruiting
Testing the Effectiveness of a Work Rehabilitation Intervention for Women with Breast Cancer Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02050750 on ClinicalTrials.gov ↗ ← All trials in Ireland